ALDARA از شرکت BAUSCH

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

ALDARA از شرکت BAUSCH

New Drug Application (NDA): 020723

Company: BAUSCH

Drug NameActive IngredientsStrengthDosage Form/RouteMarketing StatusTE CodeRLDRS
ALDARAIMIQUIMOD5%CREAM;TOPICALPrescription

AB

YesYes
Original Approvals or Tentative Approvals
Action DateSubmissionAction TypeSubmission ClassificationReview Priority; Orphan StatusLetters, Reviews, Labels, Patient Package InsertNotesUrl
02/27/1997ORIG-1 Approval

Type 1 – New Molecular Entity

STANDARD

Label is not available on this site.

Supplements
Action DateSubmissionSupplement Categories or Approval TypeLetters, Reviews, Labels, Patient Package InsertNoteUrl
02/03/2015SUPPL-26 Manufacturing (CMC)

Label is not available on this site.

11/26/2014SUPPL-25 Manufacturing (CMC)

Label is not available on this site.

10/14/2010SUPPL-22 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020723s022lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020723s022ltr.pdf

03/22/2007SUPPL-20 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020723s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020723s020LTR.pdf

08/09/2005SUPPL-18 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020723s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020723s018ltr.pdf

07/14/2004SUPPL-16 Efficacy-New Indication

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20723s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20723s016ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020723_S016_ALDARA_CREAM.pdf

03/02/2004SUPPL-15 Efficacy-New Indication

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20723se1-015_aldara_lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20723se1-015ltr.pdf

09/03/2002SUPPL-12 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20723s11s12lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20723slr011,012ltr.pdf

09/03/2002SUPPL-11 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20723s11s12lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20723slr011,012ltr.pdf

12/15/2002SUPPL-10 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20723s11s12lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20723slr010ltr.pdf

03/28/2001SUPPL-9 Manufacturing (CMC)-Control

Label is not available on this site.

09/27/2000SUPPL-8 Manufacturing (CMC)-Control

Label is not available on this site.

03/07/2000SUPPL-7 Manufacturing (CMC)-Control

Label is not available on this site.

03/07/2000SUPPL-6 Manufacturing (CMC)-Control

Label is not available on this site.

02/20/1998SUPPL-4 Manufacturing (CMC)-Control

Label is not available on this site.

12/08/1997SUPPL-3 Manufacturing (CMC)-Control

Label is not available on this site.

11/07/1997SUPPL-2 Manufacturing (CMC)-Control

Label is not available on this site.

12/08/2001SUPPL-1 Labeling

Label (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20723s1lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/020723Orig1s001.pdf

Action DateSubmissionSupplement Categories or Approval TypeLetters, Reviews, Labels,
Patient Package Insert
NoteUrl
10/14/2010SUPPL-22

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020723s022lbl.pdf
03/22/2007SUPPL-20

Efficacy-Labeling Change With Clinical Data

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020723s020lbl.pdf
08/09/2005SUPPL-18

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020723s018lbl.pdf
07/14/2004SUPPL-16

Efficacy-New Indication

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20723s016lbl.pdf
03/02/2004SUPPL-15

Efficacy-New Indication

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20723se1-015_aldara_lbl.pdf
12/15/2002SUPPL-10

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20723s11s12lbl.pdf
09/03/2002SUPPL-12

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20723s11s12lbl.pdf
09/03/2002SUPPL-11

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20723s11s12lbl.pdf
12/08/2001SUPPL-1

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20723s1lbl.pdf

ALDARA

CREAM;TOPICAL; 5%

TE Code = AB

Drug NameActive IngredientsStrengthDosage Form/RouteMarketing StatusRLDTE CodeApplication No.Company
ALDARAIMIQUIMOD5%CREAM;TOPICALPrescriptionYesAB020723BAUSCH
IMIQUIMODIMIQUIMOD5%CREAM;TOPICALPrescriptionNoAB091308APOTEX INC
IMIQUIMODIMIQUIMOD5%CREAM;TOPICALPrescriptionNoAB078548FOUGERA PHARMS
IMIQUIMODIMIQUIMOD5%CREAM;TOPICALPrescriptionNoAB201994GLENMARK GENERICS
IMIQUIMODIMIQUIMOD5%CREAM;TOPICALPrescriptionNoAB078837PERRIGO ISRAEL
IMIQUIMODIMIQUIMOD5%CREAM;TOPICALPrescriptionNoAB200173TARO
حتما بخوانید : ALDACTAZIDE از شرکت PFIZER
بخوانید  BETAMETHASONE DIPROPIONATE از شرکت GLENMARK GENERICS
اسکرول به بالا